Display options
Share it on

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 05;4(4):e356. doi: 10.1212/NXI.0000000000000356. eCollection 2017 Jul.

Optical coherence tomography and visual evoked potentials in pediatric MS.

Neurology(R) neuroimmunology & neuroinflammation

Amy T Waldman, Grant T Liu, Amy M Lavery, Geraldine Liu, William Gaetz, Tomas S Aleman, Brenda L Banwell

Affiliations

  1. Division of Neurology (A.T.W., A.M.L., G.L., B.L.B.), Neuro-ophthalmology Service (G.T.L.), Division of Ophthalmology, and Division of Radiology (W.G.), Children's Hospital of Philadelphia, PA; and Departments of Neurology (A.T.W., B.L.B., G.T.L.), Pediatrics (A.T.W., B.L.B.), and Ophthalmology (G.T.L., T.S.A.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 28626779 PMCID: PMC5459791 DOI: 10.1212/NXI.0000000000000356

Abstract

OBJECTIVE: To determine the relative ability of optical coherence tomography (OCT) and pattern-reversal visual evoked potentials (pVEPs) to detect visual pathway involvement in pediatric-onset MS.

METHODS: Pediatric-onset MS participants (onset <18 years) and healthy controls (HCs) underwent OCT (Cirrus HD-OCT) and pVEPs. Retinal nerve fiber layer (RNFL), ganglion cell layer to inner plexiform layer (GCL-IPL), and P100 pVEP latency were measured. Generalized estimating equation models were used to compare the groups, adjusting for age and intereye correlations.

RESULTS: Twenty-four pediatric MS participants, 14 with a history of remote (>6 months) optic neuritis (ON) in one eye (8 participants) or both the eyes (6 participants), and 24 HCs were enrolled. RNFL thinning (<83 μm, 2 SDs below HC eyes) occurred in 50% of ON eyes vs 5% of non-ON eyes. Prolonged VEP latency (>109 msec) occurred in 58% of ON eyes and 55% of non-ON eyes. A clinical history of ON predicted RNFL (

CONCLUSIONS: OCT and pVEPs provide complementary but distinct insights. OCT is sensitive to retinal changes in the context of clinical ON, whereas pVEPs are useful to detect disseminated lesions of the visual pathway in children with MS.

References

  1. J Child Neurol. 2012 Dec;27(12):1517-23 - PubMed
  2. Neurology. 2009 Jul 7;73(1):46-52 - PubMed
  3. Doc Ophthalmol. 2016 Aug;133(1):1-9 - PubMed
  4. Mult Scler. 2014 Sep;20(10):1342-7 - PubMed
  5. Am J Ophthalmol. 2007 Sep;144(3):459-61 - PubMed
  6. Mult Scler. 2009 Jul;15(7):802-10 - PubMed
  7. Ann Neurol. 2011 Feb;69(2):292-302 - PubMed
  8. Mult Scler. 2008 Aug;14(7):893-905 - PubMed
  9. Doc Ophthalmol. 2003 Nov;107(3):261-70 - PubMed
  10. Mult Scler Relat Disord. 2013 May 1;3(3):326-334 - PubMed
  11. PLoS One. 2012;7(4):e34823 - PubMed
  12. J Pediatr. 2006 Jul;149(1):125-7 - PubMed
  13. Lancet Neurol. 2010 Sep;9(9):921-32 - PubMed
  14. Arch Ophthalmol. 2009 Jan;127(1):50-8 - PubMed

Publication Types

Grant support